Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 15/20 | 0.74 |
| ▸ | MMP2 | P08253 | 7/20 | 0.74 |
| ▸ | MMP8 | P22894 | 7/20 | 0.74 |
| ▸ | MMP7 | P09237 | 1/20 | 0.63 |
| ▸ | MMP9 | P14780 | 5/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6016085 | 0.85 | MMP8 (0.80) | MMP1MMP2MMP8MMP7MMP9 | |
| SCHEMBL6013895 | 0.85 | MMP8 (0.80) | MMP1MMP2MMP8MMP7MMP9 | |
| SCHEMBL3794318 | 0.85 | MMP8 (0.80) | MMP1MMP2MMP8MMP7MMP9 | |
| SCHEMBL8396457 | 0.84 | MMP1 (0.85) | MMP1MMP2MMP8MMP7MMP9 | |
| SCHEMBL7457278 | 0.80 | MMP1 (0.78) | MMP1MMP2MMP8MMP7MMP9 | |
| SCHEMBL6575485 | 0.80 | MMP1 (0.82) | MMP1MMP2MMP8MMP7MMP9 | |
| SCHEMBL3798651 | 0.80 | MMP8 (0.74) | MMP1MMP2MMP8MMP7MMP9 | |
| SCHEMBL7373606 | 0.79 | MMP1 (0.71) | MMP1MMP2MMP8MMP7MMP9 | |
| SCHEMBL4351102 | 0.79 | MMP2 (0.84) | MMP1MMP2MMP8MMP7MMP9 | |
| SCHEMBL29458410 | 0.79 | MMP2 (0.84) | MMP1MMP2MMP8MMP7MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100297025-A1 | Novel compositions magnetic particles covered with gem-bisphosphonate derivatives | GUERBET. | 2010-11-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100297025-A1 | Novel compositions magnetic particles covered with gem-bisphosphonate derivatives | PHOSPHO1, SGMS2, PTEN | MMP1 4626/4885MMP2 4848/4885MMP8 4840/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.